Premium
Urso—panacea or placebo?
Author(s) -
Neuberger James
Publication year - 2000
Publication title -
hepatology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.510310431
Subject(s) - medicine , primary biliary cirrhosis , liver transplantation , ursodeoxycholic acid , placebo , odds ratio , gastroenterology , clinical endpoint , liver disease , transplantation , cirrhosis , meta analysis , randomized controlled trial , pathology , alternative medicine
Ursodeoxycholic acid (UDCA) is the only approved treatment for primary biliary cirrhosis, but its effect on disease progression is uncertain. The aim of this study was to clarify the efficacy of UDCA in primary biliary cirrhosis.